全文获取类型
收费全文 | 2193篇 |
免费 | 93篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 30篇 |
妇产科学 | 25篇 |
基础医学 | 350篇 |
口腔科学 | 58篇 |
临床医学 | 130篇 |
内科学 | 622篇 |
皮肤病学 | 16篇 |
神经病学 | 114篇 |
特种医学 | 95篇 |
外科学 | 299篇 |
综合类 | 17篇 |
预防医学 | 38篇 |
眼科学 | 21篇 |
药学 | 131篇 |
中国医学 | 5篇 |
肿瘤学 | 333篇 |
出版年
2023年 | 8篇 |
2022年 | 14篇 |
2021年 | 51篇 |
2020年 | 28篇 |
2019年 | 41篇 |
2018年 | 36篇 |
2017年 | 26篇 |
2016年 | 33篇 |
2015年 | 27篇 |
2014年 | 50篇 |
2013年 | 66篇 |
2012年 | 99篇 |
2011年 | 120篇 |
2010年 | 87篇 |
2009年 | 67篇 |
2008年 | 133篇 |
2007年 | 158篇 |
2006年 | 133篇 |
2005年 | 165篇 |
2004年 | 139篇 |
2003年 | 150篇 |
2002年 | 161篇 |
2001年 | 22篇 |
2000年 | 31篇 |
1999年 | 44篇 |
1998年 | 61篇 |
1997年 | 37篇 |
1996年 | 30篇 |
1995年 | 26篇 |
1994年 | 25篇 |
1993年 | 18篇 |
1992年 | 18篇 |
1991年 | 18篇 |
1990年 | 15篇 |
1989年 | 11篇 |
1988年 | 12篇 |
1987年 | 9篇 |
1986年 | 12篇 |
1985年 | 12篇 |
1984年 | 10篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1981年 | 13篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1977年 | 5篇 |
1974年 | 3篇 |
1973年 | 4篇 |
1971年 | 3篇 |
1970年 | 3篇 |
排序方式: 共有2296条查询结果,搜索用时 31 毫秒
51.
52.
Y Iino N Sugamata S Owada T Tago H Sato T Yokoe M Maemura Y Morishita R Horiuchi 《Japanese journal of clinical oncology》1991,21(3):153-159
The effects of a nonsteroidal aromatase inhibitor, CGS 16949A, on female Sprague-Dawley (SD) rats with 7, 12-dimethylbenz[alpha]anthracene (DMBA)-induced mammary cancers were examined in relation to estrogen receptors (ER). Rat tumor sizes in each treated group were significantly smaller (P less than 0.05) and rat body weights in most treated groups were significantly increased (P less than 0.05) compared to those in the control group (no treatment) at all measurement points during treatment. Rat uterine weights in each treated group decreased significantly compared with those in the control group (P less than 0.05). There was no significant difference between ER-positive and ER-negative groups in tumor size, body weight or uterine weight. At increased doses of CGS 16949A in the experiment, further increases in testosterone levels and further decreases in estradiol levels were shown to occur. The results suggest the mechanisms of CGS 16949A action not to be influenced by the presence or absence of ER, but to be due to its potent aromatase inhibition of the conversion of androgens to estrogens. 相似文献
53.
54.
Li Jiaqing Shuichi Hokita Che Xiangming Shoji Natsugoe Gen Tanabe Masamichi Baba Sonshin Takao Takashi Aikou 《Gastric cancer》1998,1(2):160-165
Background. To elucidate the role that cyclin E overexpression plays in the progression of early gastric cancer, we examined the expression
of cyclin E and p53, as abnormal p53 expression is linked with cyclin E overexpression in exerting adverse affects on the cell cycle.
Methods. Specimens from 108 early gastric cancers were stained by an immunohistochemical method, using anti-cyclin E and anti-p53 antibodies.
Results. The positivity rate of cyclin E expression in early gastric cancer was 33% (36/108). Cyclin E-positive tumors invaded more
deeply (P < 0.05), infiltrated lymphatic vessels more frequently (P < 0.01), showed a higher incidence of differentiated cancer (P < 0.01), and more often expressed p53 (P < 0.01) than cyclin E-negative tumors. Differentiated cancers showing coexpression of cyclin E and p53 were more likely to metastasize to the lymph nodes.
Conclusions. Overexpression of cyclin E may promote the progression of early gastric cancer.
Received for publication on Apr. 27, 1998; accepted on Nov. 17, 1998 相似文献
55.
Yoshinori Naoe Masamichi Inami Ikuo Kawamura Fusako Nishigaki Susumu Tsujimoto Sanae Matsumoto Toshitaka Manda Kyoichi Shimomura 《Cancer science》1998,89(6):666-672
FK317 is a member of a new class of bioreductive agents that exhibit strong cytotoxicity against various human cancer cells. The effect of FK317 was found to be stronger than that of mitomycin C (MMC), adriamycin (ADR) or cisplatin (CDDP). Alkaline elution analysis indicated that FK317 formed interstrand DNA-DNA and DNA-protein cross-links in cells. On the other hand, no DNA single-strand breaks were observed in the cells treated with FK317. In a cell-free system the deacetylated metabolites produced cross-linked DNA under reductive conditions, though FK317 itself did not form DNA-DNA cross-links. In order to elucidate the metabolic activation mechanisms, we established an FK317-resistant subline from human non-small cell lung cancer cells (Lu99) by stepwise and brief exposure (1 h) to FK317. The resistant subline (Lu99/317) showed cross-resistance to MMC and carboquone (CQ), but not to ADR or CDDP. DT-diaphorase, which is one of the activation enzymes of MMC and CQ, was deficient in Lu99/317 cells as determined by enzyme activity assay. However, the levels of NADPH:cytochrome P450 reductase, which is another activation enzyme for MMC and CQ, were comparable in resistant and parent cell lines. Treatment of the cells with dicumarol, an inhibitor of DT-diaphorase, reduced the cytotoxicity of FK317 to Lu99 cells, but not to Lu99/317 cells. These results indicate that deacetylation of FK317 is necessary for its reductive activation, and deacetylated FK317 is reduced by DT-diaphorase to form an active metabolite, which produces DNA-DNA interstrand and DNA-protein cross-links that lead to cell death. 相似文献
56.
57.
Masamichi Hayashi Nissim Silanikove Xiaofei Chang Rajani Ravi Vui Pham Gilson Baia Keren Paz Mariana Brait David Sidransky Wayne M Koch 《Cancer biology & therapy》2015,16(8):1184-1193
Triple negative breast cancer has an extremely poor prognosis when chemotherapy is no longer effective. To overcome drug resistance, novel drug delivery systems based on nanoparticles have had remarkable success. We produced a novel nanoparticle component ‘MDC’ from milk-derived colloid. In order to evaluate the anti-cancer effect of MDC, we conducted in vitro and in vivo experiments on cancer cell lines and a primary tumor derived breast xenograft. Doxorubicin (Dox) conjugated to MDC (MDC-Dox) showed higher cancer cell growth inhibition than MDC alone especially in cell lines with high EGFR expression. In a mouse melanoma model, MDC-Dox significantly suppressed tumor growth when compared with free Dox. Moreover, in a primary tumor derived breast xenograft, one of the mice treated with MDC-Dox showed partial regression, while mice treated with free Dox failed to show any suppression of tumor growth. We have shown that a novel nanoparticle compound made of simple milk-derived colloid has the capability for drug conjugation, and serves as a tumor-specific carrier of anti-cancer drugs. Further research on its safety and ability to carry various anti-cancer drugs into multiple drug-resistant primary breast models is warranted. 相似文献
58.
59.
60.